CoChat

Effect of the Bile Acid Sequestrant Colesevelam on the Pharmacokinetics of Pioglitazone, Repaglinide, Estrogen Estradiol, Norethindrone, Levothyroxine, and Glyburide

Brown, Karen S., Armstrong, Ingrid C., Wang, Antonia, Walker, Joseph R., Noveck, Robert J., Swearingen, Dennis, Allison, Mark, Kissling, James C., Kisicki, James, Salazar, Daniel E. · 2010 · The Journal of Clinical Pharmacology
Cited by 24

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The purpose of this study was to assess effects of colesevelam on the pharmacokinetics of glyburide, levothyroxine, estrogen estradiol (EE), norethindrone (NET), pioglitazone, and repaglinide in healthy volunteers. Six drugs with a potential to interact with colesevelam were studied in open‐label, randomized clinical studies. The presence of a drug interaction was concluded if the 90% confidence intervals for the geometric least squares mean ratios of AUC 0‐t (AUC 0–48 for levothyroxine) and C max fell outside the no‐effect limits of (80.0%, 125.0%). Concomitant administration of colesevelam had no effect on the AUC 0‐t or C max of pioglitazone but significantly decreased the AUC 0‐t and C max of glyburide, levothyroxine, and EE and the C max of repaglinide and NET. AUC 0‐t and C max of glyburide and EE, but not repaglinide or NET, were significantly decreased when the drug was given 1 hour before colesevelam. When glyburide, EE, or levothyroxine was given 4 hours before colesevelam, no drug interaction was observed. Although colesevelam has a cleaner drug interaction profile than other bile acid sequestrants, it does interfere with absorption of some drugs. A 4‐hour window appears sufficient to eliminate these interactions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0091270009349378

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 24

Metadata

Authors
Brown, K. S., Armstrong, I. C., Wang, A., Walker, J. R., Noveck, R. J., Swearingen, D., Allison, M., Kissling, J. C., Kisicki, J., & Salazar, D. E.
Venue
The Journal of Clinical Pharmacology
Publisher
Wiley
Published
2010-05
Volume
50
Issue
5
Pages
554-565
ISSN
  • 0021-9754 (ISSN-L)
  • 0091-2700
  • 1552-4604
OpenAlex
W2083270733
Cited by
24
References
2
FWCI
1.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of the Bile Acid Sequestrant Colesevelam on the Pharmacokinetics of Pioglitazone, Repaglinide, Estrogen Estradiol, Norethindrone, Levothyroxine, and Glyburide. https://app.cochat.ai/papers/10.1177/0091270009349378
The paper
Brown, K. S., Armstrong, I. C., Wang, A., Walker, J. R., Noveck, R. J., Swearingen, D., Allison, M., Kissling, J. C., Kisicki, J., & Salazar, D. E. (2010). Effect of the Bile Acid Sequestrant Colesevelam on the Pharmacokinetics of Pioglitazone, Repaglinide, Estrogen Estradiol, Norethindrone, Levothyroxine, and Glyburide. The Journal of Clinical Pharmacology. https://doi.org/10.1177/0091270009349378

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.